2019
DOI: 10.1016/j.bcab.2018.11.020
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of advanced glycation end products formation and inflammation in C. elegans: Studies of potential of Lyngbya sp. against expression of stress related genes and Live cell imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 43 publications
0
7
0
Order By: Relevance
“…The marine cyanobacteria Lyngbya spp. are, to date the most productive source of bioactive cyanobacterial compounds [76] and show potent anti-oxidant, anti-inflammatory, anti-diabetic and anti-cancer activity [19,77]. In particular, lipopeptides isolated from the cyanobacterium Lyngbia majuscula have shown a spectrum of biological activities consistent with their functioning as defense metabolites, including sodium channel blocking activity and arthropod and fish toxicity [78,79].…”
Section: Cyanobacteriamentioning
confidence: 99%
“…The marine cyanobacteria Lyngbya spp. are, to date the most productive source of bioactive cyanobacterial compounds [76] and show potent anti-oxidant, anti-inflammatory, anti-diabetic and anti-cancer activity [19,77]. In particular, lipopeptides isolated from the cyanobacterium Lyngbia majuscula have shown a spectrum of biological activities consistent with their functioning as defense metabolites, including sodium channel blocking activity and arthropod and fish toxicity [78,79].…”
Section: Cyanobacteriamentioning
confidence: 99%
“…The cyanobacteria genus Lyngbya has been extensively studied regarding its antioxidant and anti-inflammatory potential. Ethanolic extract from strains of this genus demonstrated an antioxidant activity that exceeded the one from the standard ascorbic acid and a lower IC 50 value than the standard phloroglucinol (16.42 ± 0.28 µg/mL vs. 52.57 ± 0 µg/mL, respectively), in vitro [124]. These in vitro results were then confirmed in a hyperglycemic C. elegans model with live cell imaging by HCS and by the fluorescent quantification of advanced glycation end products (AGEs).…”
Section: Cyanobacteria Potential In Alzheimer Diseasementioning
confidence: 82%
“…AGEs formation in nematodes treated with the ethanolic extract showed a prominent decrease comparing with the non-treated [124]. In addition to the antioxidant studies, the anti-inflammatory activity was also studied through the nitric oxide (NO) radical scavenging assay and by exposing C. elegans TJ356 daf16 to Pseudomonas aeruginosa [124]. Results revealed a noticeable NO scavenging activity and prevention of the induced inflammatory response of the C. elegans treated with the ethanolic extract.…”
Section: Cyanobacteria Potential In Alzheimer Diseasementioning
confidence: 98%
See 2 more Smart Citations